Minireviews
Copyright ©The Author(s) 2024.
World J Gastroenterol. Apr 21, 2024; 30(15): 2109-2117
Published online Apr 21, 2024. doi: 10.3748/wjg.v30.i15.2109
Figure 1
Figure 1 Role of musculoskeletal alterations in clinical management of patients with hepatocellular carcinoma. Various factors contribute to musculoskeletal decline in patients with hepatocellular carcinoma. A multiscale and multidisciplinary approach should be used to assess musculoskeletal health. aBMD: Areal bone mineral density; BMC: Bone mineral content; HCC: Hepatocellular carcinoma; FRAX: Fracture risk assessment tool; BTMs: Bone turnover markers; ALM: Appendicular lean mass; FFMA: Fat-free muscle area; PMI: Psoas muscle index; SMA: Skeletal muscle area; SMI: Skeletal muscle index.